383.25
-25.59 (-6.26%)
-25.59 (-6.26%)
Upgrade to Real-Time
Afterhours
Low
65.4899
High
497.17
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -25.59 | -6.26% | 383.25 | 19:41:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 399.77 | 376.03 | 403.2957 | 384.21 | 408.84 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 383.25 | 383.50 | 0.25 | 1 | 1 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 291,818 | 15,928,390 | $ 387.31 | $ 6,169,183,795 | - | 65.4899 - 497.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:42:55 | 1 | $ 383.26 | USD |
Period:
Draw Mode:
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 154.70B | 403.65M | 295.52M | $ 803.40M | $ 400.01M | -1.95 | 55.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -674.27k | 5.80% |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 424.30 | 458.50 | 376.03 | 431.67 | 10,843,640 | -41.05 | -9.67% |
| 1 Month | 375.96 | 464.85 | 370.50 | 427.28 | 13,594,634 | 7.29 | 1.94% |
| 3 Months | 229.09 | 497.17 | 214.07 | 375.85 | 19,068,913 | 154.16 | 67.29% |
| 6 Months | 130.11 | 497.17 | 117.3411 | 303.21 | 13,923,942 | 253.14 | 194.56% |
| 1 Year | 69.53 | 497.17 | 65.4899 | 209.21 | 15,097,118 | 313.72 | 451.2% |
| 3 Years | 22.00 | 497.17 | 11.54 | 131.75 | 10,652,970 | 361.25 | 1,642.05% |
| 5 Years | 22.00 | 497.17 | 11.54 | 131.75 | 10,652,970 | 361.25 | 1,642.05% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
